|
FYTTD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58581999999408E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.034540E-04 |
| Normal-vs-Stage2 |
3.838400E-02 |
| Normal-vs-Stage3 |
3.52730000000578E-05 |
| Normal-vs-Stage4 |
3.7874999999632E-06 |
| Stage1-vs-Stage2 |
8.879000E-01 |
| Stage1-vs-Stage3 |
1.021180E-01 |
| Stage1-vs-Stage4 |
5.264200E-02 |
| Stage2-vs-Stage3 |
3.412600E-01 |
| Stage2-vs-Stage4 |
2.375200E-01 |
| Stage3-vs-Stage4 |
7.226600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.5409999999978E-05 |
| Normal-vs-AfricanAmerican |
2.30779999998987E-06 |
| Normal-vs-Asian |
1.011010E-01 |
| Caucasian-vs-AfricanAmerican |
3.464100E-02 |
| Caucasian-vs-Asian |
8.206000E-01 |
| AfricanAmerican-vs-Asian |
5.891400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.39879999999848E-06 |
| Normal-vs-Female |
5.223600E-04 |
| Male-vs-Female |
1.451430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.482200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.367100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.84510000000859E-06 |
| Normal-vs-Age(81-100Yrs) |
6.041900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.779800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.448400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.614600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.763240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.559630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.262200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.747600E-01 |
| Normal-vs-Grade 2 |
1.202080E-02 |
| Normal-vs-Grade 3 |
6.71250000028323E-07 |
| Normal-vs-Grade 4 |
4.32939999961413E-07 |
| Grade 1-vs-Grade 2 |
5.815200E-01 |
| Grade 1-vs-Grade 3 |
4.147900E-02 |
| Grade 1-vs-Grade 4 |
2.744400E-02 |
| Grade 2-vs-Grade 3 |
1.437520E-03 |
| Grade 2-vs-Grade 4 |
1.296510E-03 |
| Grade 3-vs-Grade 4 |
1.895830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.194300E-02 |
| Normal-vs-ccB subtype |
1.86353999999112E-05 |
| ccA subtype-vs-ccB subtype |
2.464000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.792000E-04 |
| Normal-vs-N1 |
1.029650E-02 |
| N0-vs-N1 |
4.279800E-01 |
|
|
